2024-09-30-港交所-IDT_INT_L_二零二二年报_198页_5mb

报告摘要

Company Name: IDT International Limited (萬威國際有限公司)
Stock Code: 167
Website: www.idt-hk.com
Registered Office: Clarendon House, 2 Church Street, Hamilton, HM II, Bermuda
Principal Place of Business in Hong Kong: Unit 612, 6/F, Bank of America Tower, 12 Harcourt Road, Central, Hong Kong
Legal Advisors:
- Bermuda: Conyers Dill & Pearman
- Hong Kong: Peter Chen Law Office
Auditors: Forvis Mazars CPA Limited (formerly Mazars CPA Limited)
Share Registrars:
- Bermuda: Conyers Corporate Services (Bermuda) Limited
- Hong Kong: Union Registrars Limited

Executive Directors:
- Zhu Yongning (Resigned on 1 February 2024)
- Cheung Yuk Ki (Appointed on 1 February 2024)
Non-Executive Directors:
- Cui Xiao
- Ng Kwok Ying Isabella (Appointed on 1 February 2024)
- Chen Tiger Charles (Appointed on 1 February 2024)
Independent Non-Executive Directors:
- Zhou Meilin (Resigned on 1 February 2024)
- Zhou Rui (Resigned on 1 February 2024)
- Xu Jinwen

Audit Committee:
- Zhou Meilin (Resigned on 1 February 2024)
- Xu Jinwen
- Zhou Rui (Resigned on 1 February 2024)
Nomination and Corporate Governance Committee:
- Zhou Rui (Resigned on 1 February 2024)
- Zhou Meilin (Resigned on 1 February 2024)
- Xu Jinwen
Remuneration Committee:
- Xu Jinwen (Chairman)
- Zhou Meilin (Resigned on 1 February 2024)
- Zhou Rui (Resigned on 1 February 2024)
- Ng Kwok Ying Isabella (Appointed on 1 February 2024)
- Chen Tiger Charles (Appointed on 1 February 2024)

Total Revenue (FY2022): Approximately HK$2.2 million
Total Revenue (FY2021): Approximately HK$17.1 million
Change: A decrease of approximately 87.1% due to the closure of the Shenzhen factory.
Gross Loss (FY2022): Approximately HK$3.0 million
Gross Profit (FY2021): Approximately HK$1.9 million
Change: A gross loss of approximately HK$3.7 million due to inventory write-off.
Total Operating Expenses (FY2022): Approximately HK$23.5 million
Total Operating Expenses (FY2021): Approximately HK$64.8 million
Change: A decrease of approximately 63.7%, mainly due to reduced research, distribution, and general administrative expenses.
Other Income (FY2022): Approximately HK$18.8 million
Other Income (FY2021): Approximately HK$6.6 million
Change: Increase due to early lease termination.
Loss on Financial Assets (FY2022): Approximately HK$2.0 million
Loss on Financial Assets (FY2021): Approximately HK$8.8 million
Change: Due to a decrease in credit loss of trade receivables.
Impairment Loss (FY2022): Approximately HK$6.2 million
Impairment Loss (FY2021): Approximately HK$11.8 million
Change: Due to impairment of advances to suppliers, other taxes recoverable, and property, plant, and equipment.
Net Loss (FY2022): Approximately HK$21.8 million
Net Loss (FY2021): Approximately HK$84.2 million
Change: Decrease of approximately 74.1% due to cost control efforts.

Issued and Paid-Up Shares: 2,599,993,088 shares with a par value of HK$0.1 each.
Net Loss per Share (FY2022): Approximately HK$12.6 cents
Net Loss per Share (FY2021): Approximately HK$11.8 cents
Total Assets (FY2022): Approximately HK$3.3 million
Total Assets (FY2021): Approximately HK$81.3 million
Change: A significant decrease due to the closure of the Shenzhen factory.
Total Liabilities (FY2022): Approximately HK$330.9 million
Total Liabilities (FY2021): Approximately HK$386.8 million
Change: A decrease in total assets led to an increase in the gearing ratio to approximately 7,342.4% (2021: 321.9%).
Cash and Bank Balances (FY2022): Approximately HK$3.3 million
Cash and Bank Balances (FY2021): Approximately HK$52.9 million
Change: A decrease due to operational and financing activities.

The Group suspended operations at its Shenzhen factory from 5 March 2022, and the factory lease was terminated on 31 May 2022.
Operations resumed in the first quarter of 2024, and the Group began reselling electronic products under the "Oregon Scientific" trademark.
The Group established its own online retail platform and expanded its presence on Noon and Mercado Libre, both online platforms, in 2024.
The Group secured confirmed orders exceeding HK$70 million, expected to be fulfilled in the third quarter of 2024.
The Group expects long-term sustainability with improved market conditions and reduced trade war impact.

Litigation with Hong Kong Supplier (2020):
- Claimed HK$2.6 million for unilateral cancellation of purchase orders.
- Settlement amount reduced to HK$1.0 million through a Consent Summons in 2022.
- Final judgment in August 2022 required payment of approximately HK$5.5 million for subcontracting fees and HK$0.1 million for material costs.
- The Group used a restricted bank balance of HK$2.9 million to settle trade payables, with remaining subcontracting fees still outstanding.
Litigation with PRC Employees (2021):
- Ten former employees claimed compensation for breach of employment terms.
- The Group was ordered to pay approximately HK$2.8 million.
- Appeals were filed but rejected by the PRC District Court in December 2021.
- The Group continued to seek a settlement agreement as of the approval of the consolidated financial statements in 2022.

Capital Expenditure: No capital expenditure on property, plant, and equipment for FY2022.
Dividend Recommendation: No dividend was recommended for FY2022 (FY2021: Nil).

Leadership Changes: Zhu Yongning resigned as CEO in February 2024, and Cheung Yuk Ki was appointed in the same month.
Cost Reduction: The Group significantly reduced operating expenses, with research, distribution, and administrative expenses dropping by over 88% and 52%, respectively.
Operational Recovery: The Group resumed operations in Q1 2024 and has been actively working to reestablish business relationships and expand its online presence.
Financial Challenges: The Group faced a significant decline in revenue and assets, leading to a high gearing ratio and net losses.
Legal Issues: The Group had ongoing litigation and contingent liabilities related to suppliers and former employees, with some settled and others still pending.

展开完整摘要